AMPHASTAR PHARMACEUTICALS IN (AMPH) Forecast, Price Target & Analyst Ratings

NASDAQ:AMPH • US03209R1032

20.09 USD
+0.13 (+0.65%)
Last: Mar 5, 2026, 10:46 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMPHASTAR PHARMACEUTICALS IN (AMPH).

Forecast Snapshot

Consensus Price Target

Price Target
$32.20
+ 60.29% Upside

Next Earnings Forecast

Earnings Estimate
Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate$0.74
Revenue Estimate175.88M

ChartMill Buy Consensus

Rating
76.92%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$32.20
Upside
+ 60.29%
From current price of $20.09 to mean target of $32.20, Based on 13 analyst forecasts
Low
$25.25
Median
$30.60
High
$39.90

Price Target Revisions

1 Month
0.00%
3 Months
-2.56%

Price Target Summary

13 analysts have analysed AMPH and the average price target is 32.2 USD. This implies a price increase of 60.29% is expected in the next year compared to the current price of 20.09.
The average price target has been revised downward by 2.56% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AMPH Current Analyst RatingAMPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

AMPH Historical Analyst RatingsAMPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.92%
AMPH was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about AMPH.
In the previous month the buy percentage consensus was at a similar level.
AMPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-27NeedhamMaintains Buy -> Buy
2026-02-27Wells FargoMaintains Overweight -> Overweight
2025-12-09BarclaysInitiate Equal-Weight
2025-11-07NeedhamMaintains Buy -> Buy
2025-10-22NeedhamReiterate Buy -> Buy
2025-08-26B of A SecuritiesMaintains Neutral -> Neutral
2025-08-12NeedhamUpgrade Hold -> Buy
2025-08-08Piper SandlerMaintains Neutral -> Neutral
2025-05-12JP MorganDowngrade Overweight -> Neutral
2025-05-08Wells FargoMaintains Overweight -> Overweight
2025-04-10NeedhamReiterate Hold -> Hold
2025-03-21Piper SandlerMaintains Neutral -> Neutral
2025-02-04Piper SandlerDowngrade Overweight -> Neutral
2024-11-22Wells FargoInitiate Overweight
2024-08-08NeedhamReiterate Hold
2024-08-08Piper SandlerMaintains Overweight -> Overweight
2024-06-27Piper SandlerReiterate Overweight -> Overweight
2024-05-22NeedhamReiterate Hold
2024-05-09NeedhamReiterate Hold
2024-04-10NeedhamReiterate Hold
2024-03-05JP MorganInitiate Overweight
2023-11-17B of A SecuritiesInitiate Neutral
2023-07-25JefferiesReiterate Buy -> Buy
2023-05-17Wells FargoMaintains Equal-Weight -> Equal-Weight
2022-10-25Piper SandlerMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate$0.74
Revenue Estimate175.88M
Revenue Q2Q3.14%
EPS Q2Q0.39%
Number of Analysts9

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.88%
EPS (1 Month)
-0.31%
EPS (3 Months)
1.91%

Next Earnings Summary

AMPH is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.74 USD and the consensus revenue estimate is 175.88M USD.
The next earnings revenue estimate has been revised upward by 0.88% in the past 3 months.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AMPH revenue by date.AMPH revenue by date.
499M
13.98%		644.395M
29.14%		731.967M
13.59%		741.53M
1.31%		772.74M
4.21%		809.92M
4.81%		839.42M
3.64%		898.62M
7.05%		923.1M
2.72%		946.56M
2.54%		971.04M
2.59%		987.36M
1.68%
EBITDA
YoY % growth
AMPH ebitda by date.AMPH ebitda by date.
132.74M
42.14%		237.722M
79.09%		258.386M
8.69%		266.1M
2.99%		250.78M
-5.76%		264.39M
5.43%		252.71M
-4.42%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
AMPH ebit by date.AMPH ebit by date.
107.5M
53.79%		199.687M
85.76%		205.419M
2.87%		230.82M
12.37%		232.41M
0.69%		250.84M
7.93%		246.69M
-1.65%		150.96M
-38.81%		151.98M
0.68%		157.08M
3.36%		158.1M
0.65%		156.06M
-1.29%
Operating Margin
AMPH operating margin by date.AMPH operating margin by date.
21.54%30.99%28.06%31.13%30.08%30.97%29.39%16.80%16.46%16.59%16.28%15.81%
EPS
YoY % growth
AMPH eps by date.AMPH eps by date.
1.97
44.85%		3.30
67.51%		3.86
16.97%		3.52
-15.80%		3.38
3.95%		3.58
6.07%		3.92
9.31%		3.08
-21.36%		3.06
-0.66%		3.07
0.33%		3.03
-1.33%		2.95
-2.69%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.74
0.39%		0.81
-4.84%		0.96
2.69%		0.95
29.76%
Revenue
Q2Q % growth		175.88M
3.14%		185.33M
6.26%		202.63M
5.62%		197.57M
7.90%
EBITDA
Q2Q % growth		79.025M
55.25%		83.462M
18.54%		122.62M
81.19%		N/A
EBIT
Q2Q % growth		46.346M
24.28%		51.421M
21.90%		64.066M
153.03%		60.078M
1.47%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AMPH Yearly Revenue VS EstimatesAMPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
AMPH Yearly EPS VS EstimatesAMPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.42%
EPS Next 5 Year
-1.20%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.22%
Revenue Next 5 Year
4.48%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
0.12%
EBIT Next 5 Year
-1.03%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AMPHASTAR PHARMACEUTICALS IN / AMPH Forecast FAQ

Can you provide the average price target for AMPHASTAR PHARMACEUTICALS IN stock?

13 analysts have analysed AMPH and the average price target is 32.2 USD. This implies a price increase of 60.29% is expected in the next year compared to the current price of 20.09.


When does AMPHASTAR PHARMACEUTICALS IN (AMPH) report earnings?

AMPHASTAR PHARMACEUTICALS IN (AMPH) will report earnings on 2026-05-05.


Can you provide the consensus estimates for AMPHASTAR PHARMACEUTICALS IN next earnings?

The consensus EPS estimate for the next earnings of AMPHASTAR PHARMACEUTICALS IN (AMPH) is 0.74 USD and the consensus revenue estimate is 175.88M USD.


How many analysts cover AMPHASTAR PHARMACEUTICALS IN (AMPH) stock?

The number of analysts covering AMPHASTAR PHARMACEUTICALS IN (AMPH) is 13.